Medical Devices Startups

InVita Health provides software platforms for blood banks and organ transplantation centers to manage donations and medical device inventories. The company serves U.S. blood providers and deceased organ donation programs.

1 investor

A company developing in vitro testing methods to assess respiratory sensitization for regulatory compliance in chemical and pharmaceutical industries.

1 investor

InVivo Bionics develops implantable sensor systems for medical monitoring, initially focused on bladder health in urology. The company combines expertise in sensor electronics, software, and medical devices to create minimally invasive monitoring solutions with potential applications across multiple organ systems.

1 investor

Invizius develops therapeutics targeting the complement system to treat kidney disease and other disorders driven by uncontrolled immune activation. The company was founded based on research from the University of Edinburgh and operates from Glasgow Biocity.

1 investor

Invoy offers a breath-based metabolic testing tool that provides real-time, non-invasive metabolic data to help individuals and communities prevent chronic disease and change health behavior. It is positioned for public health leaders as a scalable approach to earlier intervention and lower long-term healthcare costs.

1 investor

ioLight makes a portable, high-resolution microscope that attaches to smartphones and tablets for professional-quality applications. The company develops optical technology based on a patented design.

1 investor

Iolyx is a pharmaceutical company focused on developing treatments for ocular conditions. The company assembles a team of experienced scientists, clinicians, and regulatory experts in drug development and ophthalmology.

1 investor

iota Biosciences develops bioelectronic diagnostic and therapeutic devices using ultrasound technology to improve patient care. The company partners with Astellas Pharma to bring innovative medical technologies to market.

1 investor

Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.

1 investor

Implant Preservation Devices develops orthopedic implant devices for medical and surgical applications. The company focuses on launching and commercializing orthopedic implant solutions across European and emerging markets.

1 investor

iPeace develops automated manufacturing systems for iPS cell production using biotech and engineering techniques to reduce production costs and enable mass manufacturing of clinical-grade stem cells. The company serves the regenerative medicine and pharmaceutical research sectors with mass-produced, personalized cell lines.

1 investor

IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Its technology originated from research at Weill Cornell Medicine and the Hospital for Special Surgery, and it is advancing these preclinical programs toward clinical applications.

1 investor

Independence Products manufactures protective pouches and personal care supplies for patients with chronic catheters, enabling them to shower and perform daily activities safely. The company operates in the UK with in-house manufacturing, customer service, and home delivery.

1 investor

IQ Surgical is developing a platform intended to improve surgical outcomes using data and intelligence. The site is a pre-launch "Coming Soon" page with limited detail about the product.

1 investor

IQIRVO is a prescription medicine for treating primary biliary cholangitis (PBC) in adults, used either in combination with ursodeoxycholic acid or as a standalone treatment for patients unable to tolerate standard therapy.

1 investor

iRen develops medical technology for dialysis patients, enabling them to continue daily activities while undergoing treatment. The company aims to reduce the burden of dialysis on quality of life for people with kidney disease.

1 investor

Iris (Amoi) Technology is a contact lens manufacturer that operates automated, self-developed smart production lines and offers customized ODM/OEM services to brand partners. The company focuses on the design, development, and production of contact lenses.

1 investor

iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases. A NuXcel spinoff based in Minneapolis, it develops implantable neuromodulation therapies targeting large patient populations with unmet clinical needs.

1 investor

Isabl develops genomic sequencing technology for cancer diagnosis, enabling whole genome and transcriptome testing in clinically relevant timeframes to provide comprehensive treatment options. The platform serves physicians and cancer patients globally by making advanced molecular diagnostics accessible.

1 investor

Isabl develops whole genome and transcriptome sequencing technology for cancer diagnosis, delivering comprehensive genomic profiling and treatment options to physicians and research teams. The company provides rapid cancer diagnostic tests in clinically relevant timeframes to improve outcomes for cancer patients globally.

1 investor

ISCARE is a private clinic in the Czech Republic offering health services covered by insurance, with specialties including gynecology, reproductive medicine (infertility treatment), orthopedics, plastic surgery, gastroenterology, andrology, vein surgery, rheumatology, and one-day surgery. It provides outpatient diagnostics, surgical procedures, and inpatient care to patients.

1 investor

Isomab develops first-in-class antibody therapies targeting specific VEGF-A isoforms to restore blood vessel growth and improve blood flow in cardiovascular diseases. The company was spun out of the University of Nottingham in 2022 and builds on over 20 years of vascular biology research.

1 investor

ITL BioMedical develops medical devices focused on needle safety and sample handling for healthcare and veterinary professionals. Its products serve blood banks and centers, microbiology and cellular therapy labs, hospitals and clinics, and animal health markets.

1 investor

ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio. The company manufactures and supplies medical radioisotopes including Lutetium-177 and Actinium-225 for cancer detection and treatment.

1 investor